Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | +2.65% | -1.39% | -37.90% |
Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 75.33M | Sales 2025 * | 164M 107M | Capitalization | 337M 220M |
---|---|---|---|---|---|
Net income 2024 * | -56M -36.58M | Net income 2025 * | -17M -11.1M | EV / Sales 2024 * | 2.75 x |
Net cash position 2024 * | 19.8M 12.93M | Net cash position 2025 * | 1.85M 1.21M | EV / Sales 2025 * | 2.05 x |
P/E ratio 2024 * |
-6.23
x | P/E ratio 2025 * |
-31.5
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.34% |
Latest transcript on AVITA Medical, Inc.
1 day | +2.65% | ||
1 week | -1.39% | ||
Current month | -46.85% | ||
1 month | -46.72% | ||
3 months | -48.77% | ||
6 months | -9.75% | ||
Current year | -37.90% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 4 M€ | -5.15% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 8.52 | +2.65% | 285,980 |
24-04-25 | 8.3 | -3.15% | 251,806 |
24-04-24 | 8.57 | -4.57% | 149,342 |
24-04-23 | 8.98 | +5.03% | 201,977 |
24-04-22 | 8.55 | -1.04% | 555,118 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.90% | 220M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- RCEL Stock